STAGE II BLADDER CANCER AJCC V8
Clinical trials for STAGE II BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to boost bladder cancer survival with Immune-Boosting drug
Disease control OngoingThis large, late-stage trial is testing whether adding an immunotherapy drug (atezolizumab) to the standard treatment of chemotherapy and radiation improves results for patients with muscle-invasive bladder cancer. The goal is to better control the cancer and help patients keep t…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Targeted drug combo tested to fight tough bladder cancer
Disease control TerminatedThis study aimed to see if a targeted pill (erdafitinib) alone or combined with an immunotherapy drug (atezolizumab) could shrink aggressive bladder tumors before surgery. It was for patients whose cancer had grown into the muscle wall of the bladder and who could not receive the…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC